Navigation Links
JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes
Date:5/10/2011

se events commonly observed with SYMLIN when co-administered with insulin were mostly gastrointestinal in nature, including nausea, which was the most frequently reported adverse event. The incidence of nausea was higher at the beginning of SYMLIN treatment and decreased with time in most patients. The incidence and severity of nausea are reduced when SYMLIN is gradually increased to the recommended doses.

About JDRF

JDRF is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump - each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.5 billion to diabetes research, including $107 million last year. More than 80 percent of JDRF's expenditures directly support research and research-related education. For more information, please visit www.jdrf.org.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development, and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) inj
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Juvenile Diabetes Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amylin Pharmaceuticals to Present at the Bank of America 2011 Healthcare Conference
2. Amylin Pharmaceuticals to Present at the Deutsche Bank 36th Annual Healthcare Conference
3. Amylin Pharmaceuticals Reports First Quarter Financial Results
4. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
5. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
6. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
7. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
8. Amylin Pharmaceuticals Reports 2010 Financial Results
9. Amylin Pharmaceuticals to Webcast Year-End Financial Results
10. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015 Allowing more ... could reduce drug overdose deaths that involve opioids, according ... study, "Disparity in Naloxone Administration by Emergency Medical Service ... Communities," published in the American Journal of Public ... deaths in the United States ...
(Date:4/24/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, announced the Company will hold a conference call ... to discuss the 1st quarter 2015 results. ... by dialing 1-888-346-3479. International participants should call 1-412-902-4260. Canadian ... joined into the IGI Laboratories, Inc. call. ...
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3
(Date:4/24/2015)... 2015 As the nation recognizes the ... sacrifices of these young men and women, the “Alaska ... and their Families” presents a special training session on ... gain a better understanding of the effect of childhood ... those – civilian and military – who provide services ...
(Date:4/24/2015)... 24, 2015 The 1975 have ... constantly across the globe to theaters, festivals and TV performances. ... they’ve partnered with their label, Dirty Hit Records, to provide ... with the newly launched Cadence & Cause website, ... LP on vinyl and a signed photo card. Entries ...
(Date:4/24/2015)... 24, 2015 Anchor Health Administrators (Anchor), ... Professionals, today announced their exclusive agreement with LTC Solutions ... Care Insurance distribution partner. , Anchor has more than ... Insurance benefits for associations, and is currently the designated ... Long Term Care Insurance member benefit. , “I am ...
(Date:4/24/2015)... 24, 2015 Insuranceautoquote.info has released a ... insurance premiums . , Lowering auto insurance prices ... to simply find better offers for their financial budget. ... it does not require any registration. , Comparing ... There are multiple agencies that sell coverage and this ...
(Date:4/24/2015)... 24, 2015 Telematics Berlin is the ... tier 1 & 2 suppliers, content providers, associations and ... in the value chain, see them converge in Berlin. ... only hear from those companies currently at the forefront ... partners. Working on customer centric products, ParkTAG are one ...
Breaking Medicine News(10 mins):Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3
... Cardium Therapeutics,(NYSE Alternext: CXM) and its operating ... adoption of procedures designed to promote,temperature modulation therapy ... in The New York Times . ... 2008, reports that New York City ambulances will ...
... today,announced that its employees committed more than $1 million ... This amount is the,result of personal giving by associates ... , "In this ... in need of help," said Mark Wagar, president and,CEO ...
... Seniors, Access to Quality Care, LTC Jobs Base , ... Commenting on the legislative year ahead as well as the ... nursing facilities (SNFs) should not receive a market basket cost ... term care advocacy organizations today said the sector supports and ...
... controls for intravenous use, standardization of practices , , FRIDAY, ... their own pain medication intravenously is four times more ... a new study says. , The report, ... Commission Journal on Quality and Patient Safety , shows ...
... Systems (NYSE: VAR ) announced today that its Board ... for February 12, 2009 with a record date of December 15, ... 4290 El Camino Real, Palo Alto, California at 4:30 p.m. PT. ... webcast by Thomson Financial and can be accessed at Varian Medical ...
... LLC, creator,of the Sensible Portions brand, is teaming with the ... the IZOD CENTER. , ... Nets are recognizing the,need to provide fans with healthier in-game ... Crisps, which are,baked, all natural, and contain no trans fat, ...
Cached Medicine News:Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 2Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 3Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 4Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 5Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 6Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 7Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 8Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 9Health News:Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008 2Health News:Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus 2Health News:Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus 3Health News:Self-Dosing Pain Medication Errors Too Common: Study 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Nets Provide Fans with Healthy In-Game Snack Option 2
... Recently updated with a high ... the new Kowa Non Myd - ... quality, style and ease of use. ... comprehensive, easy to install VK-2 image ...
The quick access to diabetic screening, panoramic images of the retina including peripheral area are available by using easy, semi automatic guidance of peripheral fixation....
Measurement of progressive multi-focal lenses is fast and easy with the CLM-3100P auto-lensmeter. The data is represented in a simple to understand graphic display....
Autolensmeter with color 5.7 inch LCD screen and built in printer....
Medicine Products: